A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT03516084 · TERMINATED
Trial details
- NCT number
- NCT03516084
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-20
- Primary completion
- 2020-02-21
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.